Phase IV Evaluation of the Adrenal Suppression Potential and PKPD of Halobetasol Propionate Foam, 0.05% in Adolescent Subjects with Plaque Psoriasis. J of Skin. 2021;5(6):s47. doi:10.25251/skin.5.supp.47